eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2010
vol. 14
 
Share:
Share:
abstract:
Review paper

Prognostic significance of CEBPA gene mutations in patients with acute myeloid leukemia

Marzena Pieronkiewicz
,
Krzysztof Lewandowski

Współczesna Onkologia (2010) vol. 14; 6 (363–371)
Online publish date: 2011/01/03
View full text Get citation
 
PlumX metrics:
Transcription factors play important role in the process of cells differentiation and intracellular signalling. The gene encoding CEBPA transcription factor is one of the master regulators of granulopoiesis. Mutations of CEBPA are presumed to be involved in emergence and progression of acute myeloid leukemia (AML) and are associated with good prognosis in AML patients. This article pinpoints the role of CEBPA in granulocyte differentiation regulation, types of CEBPA mutations and recommended methods of their identification. Independently, prognostic value of CEBPA mutations alone and with co-existing molecular defects of two other genes: NPM1, FLT3 are discussed in cases of AML with normal karyotype
keywords:

CEBPA, CCAAT enhancer binding protein , granulopoiesis, acute myeloid leukemia, prognosis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.